N-linked fucosylated glycans are biomarkers for prostate cancer with a neuroendocrine and metastatic phenotype

Authors

Joseph E Ippolito, Washington University School of Medicine in St. Louis
Hani Nakhoul, Washington University School of Medicine in St. Louis
Cody Weimholt, Washington University School of Medicine in St. Louis
Elena Nunez, Washington University School of Medicine in St. Louis
Nikolaos A Trikalinos, Washington University School of Medicine in St. Louis
et al.

Journal

Molecular Cancer Research

Publication Date

1-2-2025

Volume

23

Issue

1

First Page

59

Last Page

70

Document Type

Open Access Publication

DOI

10.1158/1541-7786.MCR-24-0660

Rights and Permissions

Ippolito JE, Hartig JP, Bejar K, Nakhoul H, Sehn JK, Weimholt C, Grimsley G, Nunez E, Trikalinos NA, Chatterjee D, Kim EH, Mehta AS, Angel PM, Troyer DA, Leach RJ, Corey E, Wu JD, Drake RR. N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype. Mol Cancer Res. 2025 Jan 2;23(1):59-70. doi: 10.1158/1541-7786.MCR-24-0660 This open access article is distributed under the Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. ©2024 The Authors; Published by the American Association for Cancer Research

Recommended Citation

Ippolito, Joseph E; Nakhoul, Hani; Weimholt, Cody; Nunez, Elena; Trikalinos, Nikolaos A; and et al., "N-linked fucosylated glycans are biomarkers for prostate cancer with a neuroendocrine and metastatic phenotype." Molecular Cancer Research. 23, 1. 59 - 70. (2025).
https://digitalcommons.wustl.edu/oa_4/4632

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.